Powered by patent-pending AI Site Twins

Global Site Intelligence, feasibility and startup for any trial, anywhere

Our platform powers site selection, PI outreach, feasibility and global study startup, starting with a tiered, ranked country and site list in under 24 hours.

Get your free site list See how it works
1RyghtSitesIllustrative
Northlake Cancer InstituteTier 196
Beacon Ridge University HospitalTier 193
Seorin University HospitalTier 191
2PI Contact Agent
MO
Dr. Maya Okafor Northlake Cancer Institute
Email verifiedPhone verified
3RyghtEngageIllustrative
Outreaches executed673
Responses received604 of 673
Sites with confirmed CDAs318
Sites ready for activation187
Sites activated132

RyghtSites

A tiered, ranked country and site list for your protocol in under 24 hours.

PI Contact Agent

The best PIs, Sub-PIs, CRCs, Site Directors and best-fit contacts at any clinical trial site, each with a verified email and phone number.

RyghtEngage

Questionnaires for qualified sites, with every response tracked in a live dashboard.

RyghtStart

With an AI-assisted managed service, we work with you to accelerate startup in any country, at record speed.

Why it matters

Site selection and feasibility can make or break your timelines

Building a global country and site list through the conventional process takes about three months, and feasibility responses can add another two months before screening begins.

80%
 

of clinical trials miss their enrollment timelines

50%
 

of activated sites enroll no more than one patient

$50k
 

in cost for every day a Phase III study runs behind schedule

AI Site Twins · Patent pending

AI Site Twins power every step

Each AI Site Twin mirrors a real research site, from the trials it has run to what it can deliver for your study.

AI agents refresh every Twin from hundreds of data sources, so each ranking reflects current evidence about the site.

Explore AI Site Twins
330,000+AI Site Twins
225countries and territories
Hundredsof data sources behind every Twin
SOC 2Type II compliant platform
How Ryght works

From your protocol to activated sites

Every step draws on the same AI Site Twins, and every site response makes its Twin more complete.

01
Site selection

RyghtSites

Upload your protocol and Ryght scores every eligible site worldwide with the Ryght Score, weighted to your study. Your team receives a tiered, ranked country and site list with the evidence behind every ranking.

<24 hrsfrom protocol to a tiered and ranked country and site list
50+proprietary analytics in every score
Explore RyghtSites
Protocol-matched sites · Phase 2 oncology Illustrative
1Northlake Cancer InstituteBoston, USTier 196
2Beacon Ridge University HospitalBentonville, USTier 193
3Seorin University HospitalSeoul, KRTier 191
4Kestrel Bay Oncology CentreMelbourne, AUTier 288
5Vale Verde Cancer NetworkSão Paulo, BRTier 285
02
Investigator identification

PI Contact Agent

PI Contact Agent finds the best PIs, Sub-PIs, CRCs, Site Directors and best-fit contacts for your indication at any clinical trial site. It draws on publications, trial experience and enrollment history. Every contact includes a verified email and phone number before outreach begins.

Learn about PI Contact Agent
Investigator match · Northlake Cancer InstituteIllustrative
MO
Dr. Maya Okafor Principal Investigator · Northlake Cancer Institute
Publication scoreHigh
Trial experience in indicationStrong
Enrollment historyStrong
Engagement probabilityHigh
Email verifiedPhone verified
03
Feasibility

RyghtEngage

RyghtEngage sends feasibility questionnaires to qualified sites and manages every follow-up. Each response updates the site's Twin and your live dashboard in real time.

89.5%site engagement on a complex Phase 1b/2 oncology study, against a 10 to 50% benchmark
Explore RyghtEngage
Feasibility dashboard Illustrative
Questionnaires sent to qualified sites120
Responses received84
Interested sites58
Qualified and shortlisted41
04
Global study startup

RyghtStart

RyghtStart takes your selected sites through contracts, budgets, ethics approvals, regulatory filings and site initiation in every country. Our team works through all 13 startup steps with you, from site identification to the first site initiation visit.

6 weekssooner to first patient in a modeled global Phase 3 oncology study
Explore RyghtStart
Activation trackerIllustrative
CountryFeasibilityContractsApprovalsSIV United States Germany Japan Australia Brazil
CompleteIn progressQueued
RyghtStart

RyghtStart manages every startup step across three stages

RyghtStart is a managed service that takes your study from protocol through patient enrollment in any country.

Plan your study startup Book a Demo
A

Site selection and confirmation

B

Contracts, regulatory and ethics

C

Supply, setup and site initiation

Startup timeline · global Phase 3 oncology Weeks from final protocol. 30 countries, about 200 sites and 600 patients.
With Ryght Industry baseline Modeled
ASite selection and confirmation
BContracts, regulatory and ethics
CSupply, setup and site initiation
6 weeks sooner to first patient 3+ months sooner to 75% of sites active The Ryght timeline is modeled and includes roadmap capabilities.

Complex Phase Ib/2 oncology study · Global CRO

43 qualified sites

3.3× the sponsor's goal of 13

Goal 13 With Ryght 43
35 min to the first site response after outreach launched
Read the full case study →

Phase 3 metastatic breast cancer study · ASCO

91% site engagement

Against a typical 10–50% industry benchmark

Industry 10–50% With Ryght 91%
Read about the ASCO partnership →

Backed by

  • Foothill Ventures
  • AIX Ventures
  • LDV Partners
  • Iaso Ventures
  • Page One Ventures
  • Top Harvest Capital
  • Heuristic Capital
  • Virtue
  • Accenture Ventures

Security and compliance

  • SOC 2 Type II
  • HIPAA compliant
  • GDPR compliant

Start with your protocol

See your best-fit sites in under 24 hours

Share your protocol and get a free, tiered and ranked country and site list, with the evidence behind every ranking.

  • 330,000+ AI Site Twins
  • 225 countries and territories
  • SOC 2 Type II

Not ready yet?

Read the AI Site Twins eBook

How a living model of every research site changes site selection and feasibility.

Download the eBook →
AI Match Clinical Research Sites to Protocol
THE SOLUTION

Identify the best sites, activate faster and start enrollment sooner

Ryght AI rapidly analyzes your protocol and then instantly connects you with high-potential research sites—anywhere in the world.

Our technology streamlines site selection, accelerates activation, gets your studies enrolling patients sooner than traditional approaches, then optimizes site performance for the duration of the trial.

TEST RYGHT ON AN OLD PROTOCOL
AI TWINS

A complete, dynamic data-derived replica of every clinical research site on the planet

 

Digital AI Twin of Research Sites - Layers of Data 1
Digital AI Twin of Research Sites - Layers of Data 2